Tarsons Products Limited (TARSONS) fundamentals
Tarsons Products Limited is a listed company in Healthcare Equipment & Supplies, part of the Healthcare sector, listed on the NSE as TARSONS (ISIN INE144Z01023). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Tarsons Products Limited does
Tarsons Products Limited is an India-based labware company. The Company is engaged in designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies contract research organizations (CROs), diagnostic companies and hospitals. The Company is also engaged in the manufacturing of range a of labware products which helps scientific discovery and improve healthcare. The Company has developed a diverse range of labware products under the categories: consumables, reusables and others. The Company's consumables products include pipette tips, centrifuge ware, petri dishes, cryo ware and storage vials. Its reusable products include bottles and carboys, beakers, cylinders and racks. It also offers polymerase chain reaction (PCR) and cell culture products.
Valuation and market data
| Last close | ₹310.15 |
|---|---|
| Market capitalisation | ₹1,649 crore |
| Enterprise value | ₹1,898 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.62 |
| Price to sales (TTM) | 3.52 |
| Book value per share | ₹118.55 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Listed since | Fri Nov 26 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹362 crore | ₹31 crore | ₹23 crore | 0.00 |
| Mar 2025 | ₹338 crore | ₹58 crore | ₹43 crore | 8.03 |
| Mar 2024 | ₹291 crore | ₹69 crore | ₹51 crore | 9.63 |
| Mar 2023 | ₹295 crore | ₹109 crore | ₹81 crore | 15.17 |
| Mar 2022 | ₹309 crore | ₹135 crore | ₹101 crore | 19.46 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 47.3% |
|---|---|
| Foreign institutions (FII) | 0.2% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.1% |
| Retail and others | 52.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.